Citations (5)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Brynjar Vidarsson, Rafat Abonour, Eliot C. Williams, Robert D. Woodson, Nancy J. Turman, Kyungmann Kim, Deane F. Mosher, Susan R. Wiersma & Walter L. Longo. (2001) Fludarabine and Cytarabine as a Sequential Infusion Regimen for Treatment of Adults with Recurrent, Refractory or Poor Prognosis Acute Leukemia. Leukemia & Lymphoma 41:3-4, pages 321-331.
Read now
Read now
Articles from other publishers (4)
Lalit Saini, Joseph Brandwein, Robert Turner, Loree Larratt, Marlene Hamilton, Anthea Peters, Cynthia Wu, Nancy Zhu, Jeffery M. Patterson, Lauren Bolster, Michael Mant, Bruce Ritchie, Elena Liew, Sunita Ghosh & Irwindeep Sandhu. (2016) The fludarabine, cytarabine, and granulocyte colony-stimulating factor (FLAG) chemotherapy regimen is an alternative to anthracycline-based therapy for the treatment of acute myeloid leukemia for patients with pre-existing cardiac disease. European Journal of Haematology 97:5, pages 471-478.
Crossref
Crossref
Jerzy Hołowiecki, Sebastian Grosicki, Sławomira Kyrcz-Krzemien, Aleksander B. Skotnicki, Beata Piatkowska-Jakubas, Krzysztof Warzocha, Ilona Seferynska & Barbara Zdziarska. (2007) Daunorubicin, cytarabine and fludarabine (DAF) for remission induction in relapsed or refractory acute myeloid leukemia. Evaluation of safety, tolerance and early outcome—Polish Adult Leukemia Group (PALG) pilot study. Annals of Hematology 87:5, pages 361-367.
Crossref
Crossref
Varsha Gandhi, Min Du, Amy J. Chapman, Peng Huang, Elihu Estey, Michael J. Keating & William Plunkett. 1996. Acute Leukemias V. Acute Leukemias V
25
31
.
Gerassimos A. Pangalis, Maria K. Angelopoulou, Christos Poziopoulos, Aaron Polliack & Shamuel Gillis. 1995. Malignant Lymphomas: Biology and Treatment. Malignant Lymphomas: Biology and Treatment
151
161
.